Surface Expression and Genetic Variants of Toll-like Receptor 2 in Pulmonary Tuberculosis Patients.
Innate immunity plays an important role in the host defense against Mycobacterium tuberculosis (M. tuberculosis). Toll-like receptor-2 (TLR2) is the main receptor and one of central components in initiation of innate immunity against M. tuberculosis. The study aimed to evaluate TLR2 surface expression on peripheral blood monocytes and study its association with variants in TLR2 597T/C single nucleotide polymorphisms (SNPs) in patients with pulmonary tuberculosis. Fifty pulmonary tuberculosis patients and 50 healthy controls were investigated for TLR2 expression on CD14+ monocytes by flow cytometry and TLR2 597T/C genotyping by Tetra primer amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR). A significant increase (P < 0.001) in TLR 2 expression was detected in tuberculosis patients compared to controls. TLR2 597 TC and CC genotypes were higher in pulmonary tuberculosis patients (OR =2.79, 95% CI =1.02-7.95 and OR =4.26, 95% CI =0.40-214.00) respectively. Genotype TT was associated with reduced risk of being a case of pulmonary tuberculosis. There was no association of TLR2 surface expression on monocytes in pulmonary tuberculosis patients with different TLR2 597T/C genotypes. It is concluded that elevated expression of TLR2 on CD14+ monocytes in pulmonary tuberculosis patients confirms the role of TLR2 in host defense against M. tuberculosis. 597T/C polymorphism of TLR 2 gene may be a risk factor for susceptibility to pulmonary tuberculosis in a sample Egyptian population.